Skip to main content
. 2022 Sep 3;9(10):1528–1537. doi: 10.1002/acn3.51644

Table 1.

Demographic, clinical and imaging data.

RRMS patients Normal controls
Total number of subjects 49 40
Age at enrolment, years, (mean ± SD) 41.4 ± 9.1 37.4 ± 7.7
Gender 20 M/29F 16 M/24F
Disease duration at enrolment, years (mean ± SD) 5.6 ± 4.5 n/a
EDSS at baseline, median (range) 1.0 (0–5) n/a
EDSS at follow‐up, median (range) 1.0 (0–6) n/a
No. of patients on stable treatment 31 n/a
Lesion volume (mm3):
Baseline 5738 ± −5180 n/a
Follow‐up 6520 ± 5681 n/a
New lesions volume, (mm3) 231 ± 234 n/a
Expanding lesion volume, (mm3) 555 ± 775 n/a